Use case – Esophageal adenocarcinoma with reported amplification ofCCND1,MAP2K1,RICTOR,FGF10,FGF19,FGF3,FGF4 andMCL1. The gene discussed is MAP2K1; the disease is esophageal adenocarcinoma.